Akorn Рентабельность активов
Что обозначает Рентабельность активов в Akorn?
Рентабельность активов Akorn, Inc. является -30.36%
Какое определение для Рентабельность активов?
Рентабельность активов показывает, насколько прибыльными являются активы компании для получения дохода. Она рассчитывается путем деления чистого дохода на среднюю общую сумму активов.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Рентабельность активов компаний в Health Care сектор на OTC по сравнению с Akorn
Что делает Akorn?
Akorn, Inc., a specialty pharmaceutical company, develops, manufactures, and markets generic and branded prescription pharmaceuticals, over-the-counter (OTC) consumer health products, and animal health pharmaceuticals in the United States and internationally. The company operates in two segments, Prescription Pharmaceuticals and Consumer Health. The Prescription Pharmaceuticals segment offers generic and branded prescription pharmaceuticals in various dosage forms, including sterile ophthalmics, injectables, and inhalants; and non-sterile oral liquids, topicals, nasal sprays, and otics. Its primary products include Akten, a topical ocular anesthetic gel; AzaSite, an antibiotic used to treat bacterial conjunctivitis; Cosopt, Cosopt PF, Betimol, and Zioptan, which are used in the treatment of glaucoma; and Xopenex inhalation solution used in the treatment or prevention of bronchospasm. The Consumer Health segment manufactures and markets OTC products for the treatment of dry eye under the TheraTears brand. It also markets other OTC consumer health products comprising Mag-Ox, a magnesium supplement; and the Diabetic Tussin line of cough and cold products. In addition, this segment offers a portfolio of animal health products, such as Anased and VetaKet veterinary sedatives; Tolazine and Yobine sedative reversing agents; and Butorphic, a pain reliever. Further, the company sells its products to wholesale distributors. Akorn, Inc. was founded in 1971 and is headquartered in Lake Forest, Illinois. On May 20, 2020, Akorn, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Компании с рентабельность активов похож на Akorn
- AMAG Pharmaceuticals имеет Рентабельность активов из -30.45%
- Jade Leader имеет Рентабельность активов из -30.42%
- 48North Cannabis имеет Рентабельность активов из -30.41%
- Karuna Therapeutics Inc имеет Рентабельность активов из -30.38%
- Poxel SA имеет Рентабельность активов из -30.38%
- Fertoz имеет Рентабельность активов из -30.37%
- Akorn имеет Рентабельность активов из -30.36%
- Shellron Capital Ltd имеет Рентабельность активов из -30.35%
- Huajun International имеет Рентабельность активов из -30.34%
- Neptune Wellness Solutions Inc имеет Рентабельность активов из -30.33%
- Kingsman Minerals имеет Рентабельность активов из -30.28%
- Nuchev имеет Рентабельность активов из -30.28%
- Sundance имеет Рентабельность активов из -30.25%